Psoriasis and MS: What to Ask About Treatment Choices

Credibility

Interest

Share:2 min read

Key Takeaway

If you have both MS and psoriasis, your care team should consider all your health conditions when choosing a psoriasis treatment.

What They Found

This article reviews how doctors choose whole-body treatments for psoriasis, a condition that causes itchy, scaly skin patches. People with psoriasis may also have other health conditions, whether or not those conditions are linked to psoriasis. The authors say treatment choices can be tailored to those conditions, how much skin is affected, what has worked before, and what the person prefers. This part of the review focuses on other conditions involving inflammation, when the body's defense system stays too active, and on a past history of cancer. The abstract does not name a best treatment for people who also have MS.

Who Should Care and Why

This matters most to people living with both MS and psoriasis, as well as their caregivers and doctors. Think of choosing treatment like planning a route: your full health history helps your team avoid options that may not fit your needs. At your next visit, tell your skin doctor about your MS, all medicines you take, and any past cancer. Share which psoriasis treatments you have tried and what matters to you, such as how you prefer to take medicine. Ask your skin doctor and MS doctor to work together before you start or change a whole-body psoriasis treatment.

Important Considerations

This is a review of treatment choices, not a study that tested psoriasis treatments in people with MS. The abstract does not report results for specific medicines, so it cannot show which option is safest or works best for someone with MS. Your doctors need to consider your own health history before recommending a treatment.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Treatment Updates Clinical Trials Caregivers

Article Topics:

IL-12/23IL-17IL-23IL-36JAK inhibitorsTNF-α inhibitorsacitretinadalimumabapremilastbimekizumabbiologicbrodalumabcardiac diseasescertolizumabchronic kidney diseasecongestive heart failurecyclosporinedeucravacitinibetanerceptgolimumabguselkumabicotrokinrainflammatory bowel diseaseinfliximabixekizumablupusmalignancymethotrexatemultiple sclerosisobesitypsoriatic arthritisrisankizumabsecukinumabspesolimabsystemic therapytildrakizumabtofacitinibtraditional agentsupadacitinibustekinumab

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of the American Academy of Dermatology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News